Abstract

The pandemic caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) causing an atypical pneumonia has exposed vulnerable populations to an unprecedented global health crisis. Severe Acute Respiratory Syndrome coronavirus 2 (SARSCoV- 2) is highly infectious and has spread rapidly around the globe at an accelerated rate [1]. Originally, SARS-CoV-2 emerged in Wuhan, Hubei Province, China, during December 2019. [2,3] Following infection, admission to intensive care units is common and a case fatality rate of up to 35% has been documented.[4, 5] Several studies focusing on infected individuals from the general population have been reported; however, limited information is available on pregnancy outcomes for women with COVID-19. The physiological changes occurring during pregnancy make the mother more vulnerable to severe infections.[6] Such as, alterations in cell-mediated immunity leading to the increased susceptibility of pregnant women to be infected by intracellular organisms such as viruses. [7]